INNOVA CAPTAB
|
INNOVA CAPTAB Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 14.15 | 531.54 | 286.86 | 232.23 | 166.01 |
| CEPS(Rs) | 16.46 | 14.89 | 8.35 | 7.91 | 6.36 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 57.61 | 1,738.38 | 1,206.84 | 919.62 | 687.39 |
| Tax Rate(%) | 25.97 | 25.39 | 25.56 | 25.70 | 19.74 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.06 | 11.88 | 13.24 | 13.62 | 11.46 |
| EBIT Margin(%) | 11.86 | 11.31 | 12.21 | 11.27 | 8.52 |
| Pre Tax Margin(%) | 9.74 | 10.60 | 11.26 | 10.03 | 6.96 |
| PAT Margin (%) | 7.21 | 7.91 | 8.38 | 7.46 | 5.58 |
| Cash Profit Margin (%) | 8.39 | 8.84 | 9.74 | 10.15 | 8.58 |
| Performance Ratios | |||||
| ROA(%) | 9.99 | 12.58 | 10.48 | 11.57 | 8.72 |
| ROE(%) | 28.02 | 36.19 | 27.04 | 28.92 | 24.10 |
| ROCE(%) | 24.34 | 30.64 | 28.42 | 26.48 | 19.63 |
| Asset Turnover(x) | 1.39 | 1.59 | 1.25 | 1.55 | 1.56 |
| Sales/Fixed Asset(x) | 4.46 | 5.17 | 4.10 | 4.07 | 3.98 |
| Working Capital/Sales(x) | 5.71 | 9.56 | 7.44 | 7.37 | 11.49 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.22 | 0.19 | 0.24 | 0.25 | 0.25 |
| Receivable days | 92.58 | 79.30 | 99.91 | 86.65 | 93.14 |
| Inventory Days | 47.60 | 49.63 | 69.58 | 50.85 | 39.71 |
| Payable days | 100.16 | 88.60 | 122.96 | 108.78 | 101.39 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | - | - |
| PCE(x) | - | - | - | - | - |
| Price/Book(x) | - | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.29 | 0.26 | 0.11 | 0.16 | 0.23 |
| EV/Core EBITDA(x) | 2.15 | 2.10 | 0.81 | 1.16 | 2.01 |
| EV/EBIT(x) | 2.36 | 2.27 | 0.90 | 1.43 | 2.71 |
| EV/CE(x) | 0.35 | 0.34 | 0.11 | 0.24 | 0.36 |
| M Cap / Sales | - | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.72 | 94.94 | 10.00 | 4.92 | - |
| Core EBITDA Growth(%) | 24.21 | 77.06 | 6.94 | 27.37 | - |
| EBIT Growth(%) | 22.28 | 81.81 | 19.25 | 38.95 | - |
| PAT Growth(%) | 6.26 | 85.37 | 23.72 | 40.30 | - |
| EPS Growth(%) | -97.34 | 85.30 | 23.53 | 39.89 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.85 | 0.95 | 0.31 | 0.48 | 0.87 |
| Current Ratio(x) | 1.59 | 1.27 | 1.26 | 1.39 | 1.26 |
| Quick Ratio(x) | 1.17 | 0.86 | 0.83 | 0.89 | 0.93 |
| Interest Cover(x) | 5.60 | 16.09 | 12.80 | 9.11 | 5.44 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹2,799.4 Cr | -0.1% | 4.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -4.9% | -2.6% | 54% | Stock Analytics | |
| CIPLA | ₹120,556.0 Cr | -0.1% | 5% | 57.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹118,095.0 Cr | 8.1% | 9.1% | 25.6% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -2.4% | 10.8% | 110% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.4% | -4.8% | 30.2% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -0.1% |
4.3% |
|
| SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses
